Skip to Main Content

Cervical Cancer PSA at L&M

January 12, 2021

Cervical Cancer PSA at L&M

 .
  • 00:00Cervical cancer is a gynaecologic
  • 00:03malignancy where women are affected by
  • 00:06a cancerous growth on their service
  • 00:09and it's unfortunately the third
  • 00:12most common gynaecologic malignancy
  • 00:14that we see and trade in the
  • 00:17United States. Women who have
  • 00:20multiple sexual partners and who have
  • 00:24more exposure to HPV virus are
  • 00:28higher risk for cervical cancer.
  • 00:31Also, the women with less
  • 00:34health compliance and health
  • 00:37literacy are at increased risk
  • 00:40for cervical cancer. The solution
  • 00:43to preventing cervical cancer
  • 00:46comes from health
  • 00:47compliance and cervical screening,
  • 00:49which might be employed in one or many ways.
  • 00:53The most common way that we do use in
  • 00:56the United States is cervical cytology,
  • 01:00meaning cervical pap smears when
  • 01:02women present to their annual
  • 01:04exams to see their gynecologists.
  • 01:07They get the pop smear from the cervix,
  • 01:11which can detect precancerous cells
  • 01:13and give give us a latency or.
  • 01:16You know window where we can intervene
  • 01:19and prevent these cancers?
  • 01:21There are many advances,
  • 01:23both prevention and therapedic phases
  • 01:25of cervical cancer.
  • 01:27The one that we are most excited about
  • 01:31as far as Preventionist concern is
  • 01:35the prophylactic vaccinations that
  • 01:37we have been fortunate enough to use
  • 01:40in the US for a decade or over now,
  • 01:45and these vaccinations are extremely
  • 01:47efficacious since they give the human
  • 01:50immunity against the most commonly.
  • 01:53Seen HPV virus types and therefore we
  • 01:57can easily prevent this cancer in young
  • 02:00women by oxygenating them.